Additionally, reduction in hepatic glucokinase activity, associated with NASH and T2DM, reduces hepatic insulin-and GLP-1-dependent glucose uptake and metabolism84,85. The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatohepatitis.